Office Of Combination Products Keeps Up Work To Clarify Regulatory Process
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Combination Products says it is working hard to provide industry with a clearer framework for bringing technologies that unite drugs, devices and biologics to market
You may also be interested in...
Industry Looks To FDA’s New Combo Products Chief For Answers
FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate the relatively new area of regulation
Industry Looks To FDA’s New Combo Products Chief For Answers
FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate the relatively new area of regulation
Moves At FDA: Nguyen Tapped For Combo Office, St. Pierre Returns To OIVD
FDA has recently made several key personnel changes in areas impacting device regulation